Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-053178

EVP and CMO sold 5,651 shares at $373.25 ($2,109,236)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bozic Carmen · EVP and CMO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-17 Sale : show line 1 in the form 10b5-1 −5,651 $373.25 $2,109,236 40,603 D
Open-market sales · 5,651 sh · avg $373.25 · $2,109,236
Loading xslF345X05/doc4.xml…